Related Experiment Video
Updated: Apr 3, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep apnea, CPAP therapy, and gastroesophageal reflux symptoms: evidence from a prospective cohort study
Zhang Li1, Zhang Wo2, Du Yuxuan3
1Department of the Fourth Deployed Clinics, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Background:
Obstructive sleep apnea (OSA) frequently coexists with gastroesophageal reflux disease (GERD), yet the degree to which hypoxic burden contributes to reflux severity and whether symptoms improve with continuous positive airway pressure (CPAP) remains insufficiently defined. Objective: To investigate the cross-sectional associations of OSA severity and nocturnal hypoxic burden with GERD symptom presence and severity, and to evaluate longitudinal changes in reflux symptoms after CPAP therapy in a prospective follow-up cohort.
Methods:
In a prospective cohort of adults undergoing polysomnography, 580 participants were evaluated at baseline and stratified by GERD status using the GERD-Q (≥8 indicating GERD). OSA severity (apnea-hypopnea index, AHI) and nocturnal hypoxemia burden (T90%, minimum SpO₂, oxygen desaturation index) were compared across reflux strata. Multivariable linear and logistic regression models assessed continuous associations between sleep parameters and GERD severity. A CPAP sub-cohort of moderate-to-severe OSA with concomitant reflux (n = 150; completed follow-up, n = 112) was monitored for GERD-Q changes at 3 and 6 months.
Results:
GERD prevalence reached 29.0%. GERD-Q scores demonstrated dose-response escalation across both OSA severity and hypoxemia categories (p for trend <0.001). T90% and ODI showed stronger associations with reflux burden than AHI in fully adjusted models (T90% β = 0.81; ODI β = 0.44; both p < 0.001), while minimum SpO₂ remained inversely related (β = -0.18; p = 0.003). Logistic models confirmed increased GERD risk in moderate (OR = 1.87) and severe OSA (OR = 2.74), and in patients with marked nocturnal hypoxemia (T90 > 10%; OR = 3.42; all p < 0.001). CPAP therapy yielded progressive symptom reduction (GERD-Q - 1.92 at 3 months; -3.28 at 6 months), with clinically meaningful improvement in 69.6% at 6 months.
Conclusion:
OSA severity and nocturnal desaturation jointly predict reflux symptom burden, with hypoxic load outperforming event frequency. CPAP produced sustained GERD symptom improvement over 6 months.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Sleep Apnea
The condition is more prevalent among...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

